📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Erk5 is a mediator to TGFß1-induced loss of phenotype and function in human podocytes. (2014)

First Author: Badshah II

Attributed to: Investigation of how activation of AMP activated protein kinase (AMPK) inhibits Na+ transport across H441 lung epithelial cells. funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2014.00071

PubMed Identifier: 24795631

Publication URI: http://europepmc.org/abstract/MED/24795631

Type: Journal Article/Review

Volume: 5

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812